Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI

Por Kärki, Mari, Näntö-Salonen, Kirsti, Niinikoski, Harri, Tanner, Laura M.
Publicado no JIMD Rep (2015)

Growth Hormone Therapy Is Safe and Effective in Patients with Lysinuric Protein Intolerance

Por Niinikoski, Harri, Lapatto, Risto, Nuutinen, Matti, Tanner, Laura, Simell, Olli, Näntö-Salonen, Kirsti
Publicado em 2011

Impact of Intranasal Insulin on Insulin Antibody Affinity and Isotypes in Young Children With HLA-Conferred Susceptibility to Type 1 Diabetes

Por Ryhänen, Samppa J., Härkönen, Taina, Siljander, Heli, Näntö-Salonen, Kirsti, Simell, Tuula, Hyöty, Heikki, Ilonen, Jorma, Veijola, Riitta, Simell, Olli, Knip, Mikael
Publicado em 2011

From Genetic Risk Awareness to Overt Type 1 Diabetes: Parental stress in a placebo-controlled prevention trial

Por Goldstein, Eszter, Hermann, Robert, Renfors, Timo J., Näntö-Salonen, Kirsti M., Korhonen, Tapio, Kärkkäinen, Maarit, Veijola, Riitta K., Knip, Mikael, Simell, Tuula T., Simell, Olli G.
Publicado em 2009

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

Por Orešič, Matej, Simell, Satu, Sysi-Aho, Marko, Näntö-Salonen, Kirsti, Seppänen-Laakso, Tuulikki, Parikka, Vilhelmiina, Katajamaa, Mikko, Hekkala, Anne, Mattila, Ismo, Keskinen, Päivi, Yetukuri, Laxman, Reinikainen, Arja, Lähde, Jyrki, Suortti, Tapani, Hakalax, Jari, Simell, Tuula, Hyöty, Heikki, Veijola, Riitta, Ilonen, Jorma, Lahesmaa, Riitta, Knip, Mikael, Simell, Olli
Publicado em 2008